Literature DB >> 10767745

Control of aggression and agitation in patients with dementia: efficacy and safety of risperidone.

P P De Deyn1, I R Katz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10767745     DOI： 10.1002/1099-1166(200007)15:1+<::aid-gps168>3.0.co;2-#

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN： 0885-6230            Impact factor:   3.485


× No keyword cloud information.
  4 in total

1.  Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study.

Authors:  G Livingston; A E Walker; C L E Katona; C Cooper
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06-26       Impact factor: 10.154

Review 2.  Risperidone for the treatment of neuropsychiatric features in dementia.

Authors:  Alistair Burns; Peter P De Deyn
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

3.  Zotepine for behavioural and psychological symptoms in dementia: an open-label study.

Authors:  Michael K Rainer; Hermann A M Mucke; Christine Krüger-Rainer; Manfred Haushofer; Sigfried Kasper
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 4.  Benefit-risk considerations in the treatment of dementia with Lewy bodies.

Authors:  Margaret M Swanberg; Jeffrey L Cummings
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.